Parliamentary.ai


by Munro Research

Fetal Dopplers (Regulation) Bill


Official Summary

A Bill to regulate the sale and use of fetal dopplers; and for connected purposes.

Summary powered by AnyModel

Overview

This bill proposes a review of the sale and use of fetal dopplers in the UK, considering their impact on maternal health and exploring options for regulation, potentially including a licensing scheme. The review's findings will inform the creation of regulations to control fetal doppler sales and use.

Description

The bill mandates a review by the Secretary of State into the sale and use of fetal dopplers. This review must assess the effects of fetal doppler use on maternal health, specifically focusing on stillbirths. It will explore potential regulatory options, such as a licensing system. The Secretary of State is required to consult with the Royal College of Midwives, Kicks Count, and other relevant parties. A report on the review must be submitted to Parliament within twelve months of the bill's passage. Following this, the Secretary of State can create regulations to control fetal doppler sales and use. These regulations may establish a licensing scheme, prohibit sales and use without a license, and restrict licenses to specified medical professionals. Any such regulations require parliamentary approval. The bill applies across the UK.

Government Spending

The bill doesn't specify a direct cost to the government but will incur costs associated with the review process (staff time, consultation, report production) and the potential implementation and enforcement of any new regulations. No figures are provided in the bill text.

Groups Affected

  • Pregnant women: May face restrictions on purchasing or using fetal dopplers if a licensing scheme is introduced.
  • Medical professionals: May be subject to licensing requirements or restrictions on the use of fetal dopplers.
  • Retailers selling fetal dopplers: May experience changes in sales practices and potentially reduced sales if restrictions are put in place.
  • Manufacturers of fetal dopplers: May face new regulatory burdens and potential limitations on their products.
Full Text

Powered by nyModel

DISCLAIMER: AI technology is not 100% accurate and summaries may contain errors, use at your own risk. Munro Research holds the copyright for all summaries found this website. Reproduction for non-commercial purposes is permitted but must be displayed alongside a link to this website. Contact info@munro-research to license commercially.